Profil
Emily Faucette is currently Chief Communications Officer at Kardigan, Inc. since 2024 and SVP-Communications & Investor Relations at Talis Biomedical Corp.
since 2021.
Former roles include Senior VP-Global Corporate Affairs & IR at Portola Pharmaceuticals LLC in 2020 and Vice President-IR & Corporate Communications at Genomic Health, Inc. Education includes an undergraduate degree from American University.
Postes actifs de Emily Faucette
| Sociétés | Poste | Début |
|---|---|---|
| TALIS BIOMEDICAL CORPORATION | Investor Relations Contact | 01/01/2021 |
Anciens postes connus de Emily Faucette
| Sociétés | Poste | Fin |
|---|---|---|
| PORTOLA PHARMACEUTICALS, INC. | Investor Relations Contact | 01/07/2020 |
| GENOMIC HEALTH, INC. | Investor Relations Contact | - |
Formation de Emily Faucette
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Portola Pharmaceuticals LLC
Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics | Health Technology |
Genomic Health, Inc.
Genomic Health, Inc. Medical/Nursing ServicesHealth Services Engages in genomic-based diagnostic tests for overtreatment and optimal treatment of early stage cancer | Health Services |
American University
American University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Talis Biomedical Corp.
Talis Biomedical Corp. Medical SpecialtiesHealth Technology Manufactures testing and diagnostic instruments for infectious diseases | Health Technology |
















